Anticorps Recombinant de lapin anti-EPCR/CD201

EPCR/CD201 Recombinant Antibody for FC

Hôte / Isotype

Lapin / IgG

Réactivité testée

souris

Applications

FC

Conjugaison

FITC Plus Fluorescent Dye

CloneNo.

241853A7

N° de cat : FITC-98248

Synonymes

241853A7, Activated protein C receptor, APC receptor, CD201, Centrocyclin



Applications testées

Résultats positifs en cytométriecellules bEnd.3,

Dilution recommandée

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

FITC-98248 cible EPCR/CD201 dans les applications de FC et montre une réactivité avec des échantillons souris

Réactivité souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène EPCR/CD201 Protéine recombinante Eg1517
Nom complet protein C receptor, endothelial
Masse moléculaire calculée27kDa
Numéro d’acquisition GenBankNM_011171.2
Symbole du gène PROCR
Identification du gène (NCBI) 19124
Conjugaison FITC Plus Fluorescent Dye
Excitation/Emission maxima wavelengths495 nm / 524 nm
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.09% sodium azide
Conditions de stockageStore at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

Informations générales

EPCR, also known as CD201, protein C receptor (PROCR), or activated protein C receptor (APC receptor), is a transmembrane glycoprotein. EPCR promotes the activation of protein C, which has anticoagulant and cytoprotective effects. EPCR facilitates the activation of protein C by the thrombin-thrombomodulin complex but also facilitates APC-mediated cytoprotective effects on cells that involve the activation of protease-activated receptors (PAR) 1 and 3(PMID: 27207424).

Protocole

Product Specific Protocols
FC protocol for FITC Plus EPCR/CD201 antibody FITC-98248Download protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}